TW324009B - Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor - Google Patents

Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor

Info

Publication number
TW324009B
TW324009B TW082108741A TW82108741A TW324009B TW 324009 B TW324009 B TW 324009B TW 082108741 A TW082108741 A TW 082108741A TW 82108741 A TW82108741 A TW 82108741A TW 324009 B TW324009 B TW 324009B
Authority
TW
Taiwan
Prior art keywords
pyrazole
ring derivative
production process
condensation ring
androgen inhibitor
Prior art date
Application number
TW082108741A
Other languages
English (en)
Inventor
Hiroshi Kiyokawa
Satoshi Yamada
Keisuke Miyashima
Hiroshi Edamatsu
Kunihiko Tatsuko
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of TW324009B publication Critical patent/TW324009B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW082108741A 1992-10-20 1993-10-20 Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor TW324009B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28144692 1992-10-20
JP4542493 1993-03-05

Publications (1)

Publication Number Publication Date
TW324009B true TW324009B (en) 1998-01-01

Family

ID=26385407

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082108741A TW324009B (en) 1992-10-20 1993-10-20 Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor

Country Status (9)

Country Link
US (2) US5409928A (zh)
EP (1) EP0594149A3 (zh)
KR (1) KR940009184A (zh)
CN (1) CN1036919C (zh)
AU (1) AU667575B2 (zh)
CA (1) CA2108798A1 (zh)
MX (1) MX9306529A (zh)
PH (1) PH30288A (zh)
TW (1) TW324009B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6124289A (en) 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
ID23177A (id) * 1997-03-14 2000-03-23 Otsuka Pharma Co Ltd Turunan pirimidin baru
AU4331500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
FR2842809A1 (fr) * 2002-07-26 2004-01-30 Greenpharma Sas NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
US7208596B2 (en) 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
US7153961B2 (en) 2003-11-25 2006-12-26 Bristol-Myers Squibb Pharma Co. Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
US20100190761A1 (en) * 2007-06-20 2010-07-29 Anthony Ogawa Diphenyl substituted alkanes
WO2015151068A1 (en) * 2014-04-03 2015-10-08 Universita' Di Pisa Synthetic analogues of 3-iodothyronamine (t1am) and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786611A (fr) * 1971-08-16 1973-01-22 Int Chem & Nuclear Corp Nouveaux inhibiteurs de xanthine-oxydase et leur procede de preparatio
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
US5420128A (en) * 1990-10-09 1995-05-30 Otsuka Pharmaceutical Co., Ltd. Pyrimidine derivatives, method of manufacturing the same, and androgen inhibitor
CN1030768C (zh) * 1990-10-09 1996-01-24 大塚制药株式会社 嘧啶衍生物或其药用盐的制备方法

Also Published As

Publication number Publication date
AU667575B2 (en) 1996-03-28
EP0594149A3 (en) 1994-06-29
MX9306529A (es) 1994-04-29
US5516777A (en) 1996-05-14
AU4912093A (en) 1994-05-05
CN1036919C (zh) 1998-01-07
CA2108798A1 (en) 1994-04-21
KR940009184A (ko) 1994-05-20
PH30288A (en) 1997-02-20
EP0594149A2 (en) 1994-04-27
CN1089609A (zh) 1994-07-20
US5409928A (en) 1995-04-25

Similar Documents

Publication Publication Date Title
AU3802589A (en) Quinoline derivatives, their production and use
TW324009B (en) Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor
UA41290C2 (uk) Гетероариламіни, фармацевтична композиція, спосіб інгібування холінестерази у ссавців, спосіб покращення пам'яті
AU589427B2 (en) Pyridonecarboxylic acid derivatives and process for their preparation
DE3876813D1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
ES8704929A1 (es) Procedimiento para preparar derivados de acido quinoloncar- boxilico
IL95839A0 (en) Quinoline derivatives,their production and use
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
AU6366386A (en) 3-vinyl- and 3- ethinyl-beta-carboline derivatives their production and their use as drugs
ES8606283A1 (es) Procedimiento para preparar derivados de acidos quinolon- carboxilicos
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
EP0315434A3 (en) Pyridoxal hydrazone derivatives their production and use and pharmaceutical compositions containing the same
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
FI964278A (fi) Menetelmä 5,6-dihydroksi-2-amino-1,2,3,4-tetrahydronaftaleenin johdannaisten valmistamiseksi
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
TW326041B (en) Pyridazinone derivatives, their production process and their use for inhibition of platelet aggregation
ES8604148A1 (es) Un metodo para preparar compuestos de 1,4-dihidropiridina
MY105843A (en) Glycerol derivatives, a preparation process of the same and therapeutical compositions containing them.
ES2019228A6 (es) Procedimiento de obtencion de nuevos derivados de azaspiro (4.5) decano-7, 9-diona.
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
ES2112774A1 (es) Nuevos derivados azolicos con actividad antifungica.
ES2076865A1 (es) Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat).
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.